| pubmed-article:10235581 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10235581 | lifeskim:mentions | umls-concept:C0080103 | lld:lifeskim |
| pubmed-article:10235581 | lifeskim:mentions | umls-concept:C0278884 | lld:lifeskim |
| pubmed-article:10235581 | lifeskim:mentions | umls-concept:C0015385 | lld:lifeskim |
| pubmed-article:10235581 | lifeskim:mentions | umls-concept:C0085415 | lld:lifeskim |
| pubmed-article:10235581 | lifeskim:mentions | umls-concept:C0600688 | lld:lifeskim |
| pubmed-article:10235581 | lifeskim:mentions | umls-concept:C0396670 | lld:lifeskim |
| pubmed-article:10235581 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:10235581 | pubmed:dateCreated | 1999-5-20 | lld:pubmed |
| pubmed-article:10235581 | pubmed:abstractText | The optimal toxic reaction of the normal tissues in perfused limbs after isolated limb perfusion (ILP) is unknown. Theoretically, more severe limb toxicity could reflect a concomitant increased toxic effect to the tumor and improved outcomes. We determined whether there is a relation between limb toxicity and treatment outcomes after ILP for recurrent limb melanoma. | lld:pubmed |
| pubmed-article:10235581 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10235581 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10235581 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:10235581 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10235581 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10235581 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10235581 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10235581 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10235581 | pubmed:month | May | lld:pubmed |
| pubmed-article:10235581 | pubmed:issn | 1072-7515 | lld:pubmed |
| pubmed-article:10235581 | pubmed:author | pubmed-author:KroonB BBB | lld:pubmed |
| pubmed-article:10235581 | pubmed:author | pubmed-author:HartG AGA | lld:pubmed |
| pubmed-article:10235581 | pubmed:author | pubmed-author:EggermontA... | lld:pubmed |
| pubmed-article:10235581 | pubmed:author | pubmed-author:KlaaseJ MJM | lld:pubmed |
| pubmed-article:10235581 | pubmed:author | pubmed-author:VrouenraetsB... | lld:pubmed |
| pubmed-article:10235581 | pubmed:author | pubmed-author:van GeelB NBN | lld:pubmed |
| pubmed-article:10235581 | pubmed:author | pubmed-author:NiewegO EOE | lld:pubmed |
| pubmed-article:10235581 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10235581 | pubmed:volume | 188 | lld:pubmed |
| pubmed-article:10235581 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10235581 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10235581 | pubmed:pagination | 522-30 | lld:pubmed |
| pubmed-article:10235581 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:10235581 | pubmed:meshHeading | pubmed-meshheading:10235581... | lld:pubmed |
| pubmed-article:10235581 | pubmed:meshHeading | pubmed-meshheading:10235581... | lld:pubmed |
| pubmed-article:10235581 | pubmed:meshHeading | pubmed-meshheading:10235581... | lld:pubmed |
| pubmed-article:10235581 | pubmed:meshHeading | pubmed-meshheading:10235581... | lld:pubmed |
| pubmed-article:10235581 | pubmed:meshHeading | pubmed-meshheading:10235581... | lld:pubmed |
| pubmed-article:10235581 | pubmed:meshHeading | pubmed-meshheading:10235581... | lld:pubmed |
| pubmed-article:10235581 | pubmed:meshHeading | pubmed-meshheading:10235581... | lld:pubmed |
| pubmed-article:10235581 | pubmed:meshHeading | pubmed-meshheading:10235581... | lld:pubmed |
| pubmed-article:10235581 | pubmed:meshHeading | pubmed-meshheading:10235581... | lld:pubmed |
| pubmed-article:10235581 | pubmed:meshHeading | pubmed-meshheading:10235581... | lld:pubmed |
| pubmed-article:10235581 | pubmed:meshHeading | pubmed-meshheading:10235581... | lld:pubmed |
| pubmed-article:10235581 | pubmed:meshHeading | pubmed-meshheading:10235581... | lld:pubmed |
| pubmed-article:10235581 | pubmed:meshHeading | pubmed-meshheading:10235581... | lld:pubmed |
| pubmed-article:10235581 | pubmed:meshHeading | pubmed-meshheading:10235581... | lld:pubmed |
| pubmed-article:10235581 | pubmed:meshHeading | pubmed-meshheading:10235581... | lld:pubmed |
| pubmed-article:10235581 | pubmed:meshHeading | pubmed-meshheading:10235581... | lld:pubmed |
| pubmed-article:10235581 | pubmed:meshHeading | pubmed-meshheading:10235581... | lld:pubmed |
| pubmed-article:10235581 | pubmed:meshHeading | pubmed-meshheading:10235581... | lld:pubmed |
| pubmed-article:10235581 | pubmed:meshHeading | pubmed-meshheading:10235581... | lld:pubmed |
| pubmed-article:10235581 | pubmed:meshHeading | pubmed-meshheading:10235581... | lld:pubmed |
| pubmed-article:10235581 | pubmed:meshHeading | pubmed-meshheading:10235581... | lld:pubmed |
| pubmed-article:10235581 | pubmed:meshHeading | pubmed-meshheading:10235581... | lld:pubmed |
| pubmed-article:10235581 | pubmed:meshHeading | pubmed-meshheading:10235581... | lld:pubmed |
| pubmed-article:10235581 | pubmed:meshHeading | pubmed-meshheading:10235581... | lld:pubmed |
| pubmed-article:10235581 | pubmed:meshHeading | pubmed-meshheading:10235581... | lld:pubmed |
| pubmed-article:10235581 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10235581 | pubmed:articleTitle | Relation between limb toxicity and treatment outcomes after isolated limb perfusion for recurrent melanoma. | lld:pubmed |
| pubmed-article:10235581 | pubmed:affiliation | Department of Surgery, The Netherlands Cancer Institute (Antoni van Leeuwenhoek Ziekenhuis), Amsterdam. | lld:pubmed |
| pubmed-article:10235581 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10235581 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10235581 | lld:pubmed |
